161 filings
Page 5 of 9
6-K
w0uvmxlbtlp7pgh oreb
26 May 22
Current report (foreign)
3:00pm
6-K
jz1xmkmjqu sf
11 May 22
AnPac Bio Regains Compliance with Market-Value-Of-Publicly Held Shares Requirement upon Transfer to The Nasdaq Capital Market
8:04am
6-K
yyozpe0em66zzp
9 May 22
Current report (foreign)
7:31am
6-K
p4k1 akg6kmsz4d0
6 May 22
Nasdaq Hearing Panel Grants AnPac Bio’s Request to Transfer Securities from The Nasdaq Global Market to The Nasdaq Capital Market
8:00am
NT 20-F
fkb0ptic5tx vhv0u0hp
2 May 22
Notice of late annual filing (foreign)
5:15pm
6-K
zns3xm6
21 Apr 22
Current report (foreign)
4:07pm
6-K
bnfctg0ivdfsh lksv
11 Apr 22
AnPac Bio Appoints Dr. Aidong Chen as New Chief Executive Officer and Chairman of the Board
5:15pm
6-K
tgyb9sp8a9z7
28 Mar 22
AnPac Bio-Medical Sciences Announces Receipt of Staff Delisting Determination from Nasdaq; Intends to Request Hearing
5:00pm
6-K
flxmtn9utm
11 Mar 22
AnPac Bio-Medical Sciences Announces Receipt of NASDAQ Deficiency Notice Regarding Minimum Bid Price Requirement
4:40pm
6-K
gwmam43dy7ghwnj
15 Feb 22
Current report (foreign)
4:30pm
6-K
fqjnj l6s
24 Jan 22
AnPac Bio Receives NASDAQ Notification Regarding
5:00pm
6-K
euc5 s92agwkzhsq
26 Nov 21
Current report (foreign)
1:30pm
6-K
lpy97uv445q1xxk
15 Nov 21
Current report (foreign)
12:00am
424B5
7fuimnp63y
12 Nov 21
Prospectus supplement for primary offering
5:23pm
6-K
jon666
12 Nov 21
AnPac Bio Announces Pricing of Approximately $2.9 Million Underwritten Public Offering of American Depositary Shares
7:00am
6-K
2esuxnljxoh6gaw
12 Oct 21
Current report (foreign)
4:31pm
6-K
8m8v mdefkxmx45u4ce
4 Oct 21
AnPac Bio Study Shows Strong Correlation between CDA Score and Risk of Cancer and Diseases
7:30am
6-K
h2b03yc w0i8f
1 Oct 21
Current report (foreign)
7:30am
6-K
gyyrmpfo
30 Sep 21
AnPac Bio Receives NASDAQ Notification Regarding Minimum Market Value of Listed Securities Deficiency
5:02pm